FlyteHealth

We’re a proud leader in tech-enabled medical care for people with obesity and comorbid health conditions. Today, we are rebranding as FlyteHealth for our customer and consumer-facing brand. “As our business in the care and navigation of the best-in-class obesity medicine program continues to grow, employers, payers and patients have come to know us as Flyte. With that increased visibility, we are consolidating under FlyteHealth as a single brand,” our CEO and co-founder Sloan Saunders explains. “This alignment allows us to continue to expand our offerings with our partners and provide a unified experience.” Powered by the patent-pending Flyte Intelligence platform, FlyteHealth delivers a user-friendly experience through the FlyteHealth app, care by a team of obesity medicine experts, and patient navigation services. The FlyteHealth approach is built upon the largest data set of obesity and chronic disease research available, as well as the decades of clinical experience of FlyteHealth’s founders — obesity medicine specialists who were among the first to see obesity not as a simple issue of willpower but as a complex disease that requires expert medical treatment. To learn more about our delivery of cost-effective care for obesity and related conditions, visit https://lnkd.in/gKdCZJwf.

Did you know that nearly half of Americans may qualify for GLP-1 anti-obesity medications in the next decade? This makes FlyteHealth's mission to empower employers and payers to provide top-tier obesity care without skyrocketing costs more important than ever. Learn more in Second Opinion Media's latest health-technology newsletter, where FlyteHealth's technology-enabled approach is highlighted because we help employers keep costs down through responsible prescribing of pharmacotherapy, which can include GLP-1s. Read here: https://lnkd.in/gtr9D_Yy

At FlyteHealth, we’re committed to making sure nothing stands in the way of someone getting the care they need. We work side by side with businesses to cut through complexity and cost, and partner with healthcare systems to offer the best in obesity care to their patients without overextending their existing providers. Together, we’re a collective force for fighting chronic disease.

😴 Have you heard of #obstructivesleepapnea (#OSA)? 💔 It's a common #sleep #disorder that interrupts #breathing and can lead to #snoring, #fatigue, #bedpartnerfrustration, #heartattack, #stroke, #heartfailure, #irregularheartbeat, #type2diabetes, #depression, driving #accidents and so many other #complications. 👩⚕️ If you have #obesity, there is about a 50/50 chance that you also have OSA. We #diagnose it in our #patients constantly. ⚕ What is the best #treatment for sleep apnea among patients with obesity? #OBESITYTREATMENT 😍 And recent data reveal that #tirzepatide (GIP / #GLP-1 co-agonist) can reduce severity of OSA by greater than 50%! 🙏 Thanks Alyx Arnett for interviewing me and the #experts below for your great article in Sleep Review. Click here to learn more about the role of GLP-1s in OSA treatment: https://lnkd.in/eKK4qk3F Atul Malhotra - Anthony Izzo, DO, FAAN, FAASM - Khang Duy (Ricky) Le - Raj Dasgupta MD, FACP, FCCP, FAASM - Brandon Peters, MD, FAASM - John Cronin, MD - Eli Lilly and Company Photo credit: Sleep Review

⭐ Member motivation spotlight on FlyteHealth! Flyte Health provides a digital weight management program focused on comprehensive and medically supervised care. It combines expertise from physicians, dietitians, and behavioral specialists to deliver personalized treatment plans through its Flyte Health app. By partnering with healthcare providers and employers, Flyte Health is creating a supportive ecosystem that promotes sustained health improvements and a better quality of life for those with weight-related issues. Being a member of the V1C Coalition by the Digital Medicine Society (DiMe), FlyteHealth is networking with decision-makers to develop important partnerships. ❓ Are you interested in how your organization can benefit from the V1C Coalition? Let’s talk! Learn more and share your interest in joining here: https://bit.ly/45gTuLF #VirtualFirstCare #Collaboration #DigitalHealth

🤠 The Obesity Society's #ObesityWeek in San Antonio, TX is off to a great start.... 🌎 BEYOND EXCITED AND PROUD to see the 5 Principles of Obesity displayed all over the convention center! Last year, the International Obesity Collaborative (IOC) created these 5 principles as core #truths about #obesity everyone should know. 1) It is undeniable that obesity is a #complex, #chronic #disease. 2) Obesity is driven by powerful underlying #biology, not by #choice. 3) The many #health effects of excess weight can start early. 4) Obesity is #treatable. 5) Weight #bias, #stigma and #discrimination are #harmful. 👉 MORE ON IOC HERE: https://lnkd.in/excfaaQ2 The Obesity Society - Obesity Action Coalition - Obesity Medicine Association - Obesity Canada – Obésité Canada - IMI_SOPHIA - Academy of Nutrition and Dietetics - American Society For Metabolic And Bariatric Surgery (ASMBS) - European Association for the Study of Obesity (EASO) - ECPObesity - The STOP Obesity Alliance - GOPA - KSSO - members include Joe Nadglowski - Tracy Zvenyach, PhD, MS, RN - James Zervios - Ted Kyle - Anthony G. Comuzzie - Patty Nece - Nicole Pearce - Dawn Hatanaka - Dan Bessesen - Jeanne Blankenship, MS RDN - Theresa Faulkner - Angela Fitch MD, FACP, FOMA, Dipl. ABOM - Chris Gallagher - Cristy Gallagher - 🍏Mário Silva - Johanna Ralston - Werd Al-Najim - Ian Patton + several others 💙 FlyteHealth #OW2024 team - Leon Igel, MD, FACP, FTOS, DABOM - Jerusha Stahl - Nathan Lesch, MSN, FNP-C, BC-ADM, CDCES - Cathy Del Buono - Jessica Fields - Morgan Dickison, MS, RD, CSOWM, CDN - Louis Aronne

Heading to San Antonio for ObesityWeek®? This is your checklist to hear from FlyteHealth folks during #OW2024! Full agenda: https://lnkd.in/gtPhmJQk 📅 Nov. 2 – 3 preconference 🚪 Lone Star Ballroom ➡️Presentations by our clinical advisors, Ania Jastreboff, MD, PhD, and Amanda Velazquez, MD, DABOM. ☀️ ☀️ ☀️ 📅 3:30 – 5 p.m. Nov. 3 🚪214 ➡️Symposium “The Long-Term Use of Anti-Obesity Medications” with FlyteHealth chief medical officer, Leon Igel, MD, FACP, FTOS, DABOM, speaking about “Adding, Subtracting, Starting, Stopping Anti-Obesity Medicines.” ☀️ ☀️ ☀️ 📅8 – 9:30 a.m. Nov. 4 🚪205 ➡️Consultation workshop with FlyteHealth co-founder Katherine Saunders, MD, and chief medical officer, Leon Igel, MD, FACP, FTOS, DABOM. ☀️ ☀️ ☀️ 📅1:30 – 2:30 p.m. Nov. 4 🚪Lila Cockrell Theatre ➡️Key lecture “Achieving the Quintuple Aims of Care in Obesity Treatment” with FlyteHealth clinical advisor Lee Kaplan, MD. ☀️ ☀️ ☀️ 📅1:30 – 2:30 p.m. Nov. 4 🚪205 ➡️Consultation workshop with FlyteHealth clinical advisor Amanda Velazquez, MD, DABOM. ☀️ ☀️ ☀️ 📅3:30 – 5 p.m. Nov. 4 🚪Lila Cockrell Theatre ➡️Clinical orals session “SURMOUNT-1 Three Year Outcomes” with FlyteHealth co-founder Louis Aronne, MD, and clinical advisor Ania Jastreboff, MD, PhD. ☀️ ☀️ ☀️ 📅3:30 – 5 p.m. Nov. 4 🚪205 ➡️Consultation workshop with FlyteHealth clinical advisor Lee Kaplan, MD. ☀️ ☀️ ☀️ 📅5:30 – 6:30 p.m. Nov. 4 🚪Lila Cockrell Theatre ➡️Key lecture “How Do We Know When Enough is Enough” by FlyteHealth co-founder Louis Aronne, MD. ☀️ ☀️ ☀️ 📅8:30 – 8:45 a.m. Nov. 6 🚪207 ➡️Oral session “Comparison of Weight Loss Medication Decisions” with FlyteHealth clinical advisor Caroline Apovian, MD. ✈️See you there!

If you’re attending the preconference portion of ObesityWeek® Nov. 2 and 3, you’ll learn from two of our clinical advisors, Ania Jastreboff, MD, PhD, and Amanda Velazquez, MD, DABOM. They will help primary care physicians, academics and interprofessional team members explore the complexities of effectively treating obesity.

Making your schedule for ObesityWeek®? Don’t miss our chief medical officer, Leon Igel, MD, FACP, FTOS, DABOM! He is presenting during the symposium “The Long-Term Use of Anti-Obesity Medications” Nov. 3. The symposium is 3:30 to 5 p.m. and Dr. Igel will speak from 3:50 to 4:10 p.m. about “Adding, Subtracting, Starting, Stopping Anti-Obesity Medicines” in Room 214.

Don’t miss our co-founder’s key lecture during ObesityWeek®! Louis Aronne, MD, will explore controversies surrounding determining optimal weight loss. Look for “How Do We Know When Enough is Enough? Controversies in Determining Optimal Weight Loss” 5:30 p.m. Nov. 4 in the Lila Cockrell Theatre. A moderated Q-and-A will follow.